Targeting LRP6: A new strategy for cancer therapy
Targeting specific molecular drivers of tumor growth is a key approach in cancer therapy. Among these targets, the low-density lipoprotein receptor-related protein 6 (LRP6), a vital component of the Wnt signaling pathway, has emerged as an intriguing candidate. As a cell-surface receptor and vital c...
Saved in:
Main Authors: | Wei Xue (Author), Bo Zhu (Author), Kaili Zhao (Author), Qiuju Huang (Author), Hua Luo (Author), Yiwen Shou (Author), Zhaoquan Huang (Author), Hongwei Guo (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research progress on the chemical components and biological activities of sea cucumber polypeptides
by: Yiwen Shou, et al.
Published: (2023) -
Garlic-derived compound S-allylmercaptocysteine inhibits hepatocarcinogenesis through targeting LRP6/Wnt pathway
by: Jia Xiao, et al.
Published: (2018) -
miR-202-3p Regulates Sertoli Cell Proliferation, Synthesis Function, and Apoptosis by Targeting LRP6 and Cyclin D1 of Wnt/β-Catenin Signaling
by: Chao Yang, et al.
Published: (2019) -
The role of Lrp6-mediated Wnt/β-catenin signaling in the development and intervention of spinal neural tube defects in mice
by: Tianyu Zhao, et al.
Published: (2022) -
Gentisic acid prevents the development of atherosclerotic lesions by inhibiting SNX10-mediated stabilization of LRP6
by: Tongqing Chen, et al.
Published: (2024)